United Therapeutics
Brett Gunn is a seasoned finance professional with over two decades of experience in accounting and finance roles. Currently serving as Senior Director, Finance and Controller at United Therapeutics Corporation since November 2016, Brett has held various positions including Director of Revenue and Associate Director of Revenue Accounting. Prior to this, Brett worked at W.L. Gore & Associates as Corporate Accounting and Reporting Leader and European Technical Accountant. Brett's career began at Deloitte, where roles included Audit Senior Manager and Audit Manager, and at Arthur Andersen as Audit Staff. Brett holds a degree in Business with a focus on Accounting from the University of North Carolina at Chapel Hill, having completed studies at UNC Kenan-Flagler Business School.
This person is not in any teams
United Therapeutics
12 followers
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.